Track iSTOXX Single Stock on Assicurazioni Generali GR Decrement 1.07 Price EUR Index (Q1K1) price, historical values, financial information, price forecast, and insights to empower your investing ...

At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...